Tuttiquotidiani e completamente gratuito. Ogni giorno aggreghiamo notizie da oltre 100 testate e generiamo sintesi AI originali per te. Aiutaci a mantenere il servizio attivo con una piccola donazione, oppure diventa TQ Pro da solo 1€/mese.

Buy this biotech stock on pivot to immune disease treatments, Wells Fargo says

  • Posted on April 20, 2026
  • By CNBC
  • 0 Views
  • 1 min read
Buy this biotech stock on pivot to immune disease treatments, Wells Fargo says
Buy this biotech stock on pivot to immune disease treatments, Wells Fargo says

The bank's research arm raised its rating on the stock to overweight from equal weight.
continue reading...

Author
CNBC

You May Also Like